4/A

FORM 4/A SUBMISSION

Company: Amylyx Pharmaceuticals, Inc.
Filed: April 26, 2023
Period of Report: January 6, 2022
Accession Number: 0000899243-23-011781

View Document ↗ View on SEC.gov ↗